Biotech IPO Shares Climb in Trading Debuts After Deals Upsized
Source: Live Mint (Bloomberg) — A trio of biotech companies’ shares rose in their first trading sessions after they each sold more shares in their respective initial public offerings than they had planned. Bicara Therapeutics Inc. shares climbed 42% to $25.50 apiece as of 1:22 p.m. on Friday. The company had expanded its IPO to…